SCHEMBL7652008

SCHEMBL7652008

COc1cccc(C(=O)C=CC2=COC(Cc3ccccc3)O2)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.47
ABCG2 Q9UNQ0 2/20 0.44
CYP1A1 P04798 2/20 0.43
CYP1B1 Q16678 2/20 0.43
CYP1A2 P05177 1/20 0.43
GPR52 Q9Y2T5 1/20 0.42
AR P10275 2/20 0.41
MAOB P27338 2/20 0.41
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK14 Q16539 1/20 0.40
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
KMT2A Q03164 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ABCB1 P08183 1/20 0.38
APP P05067 1/20 0.37
KCNA3 P22001 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7657631 0.88 CYP1A1 (0.43) NR1H4ABCG2CYP1A1CYP1B1CYP1A2
SCHEMBL7656619 0.86 AURKA (0.48) NR1H4ABCG2ARMAOBCYP2C9
SCHEMBL7652711 0.81 ABCG2 (0.60) ABCG2MAOBCYP2C19MAPTMEN1
SCHEMBL7662659 0.81 MAPT (0.50) NR1H4ABCG2MAOBCYP2C9CYP2C19
SCHEMBL7664550 0.78 MAPT (0.43) ARMAOBMAPTNPC1RAB9A
SCHEMBL7664988 0.77 AR (0.52) ARMAPTMEN1KMT2ANPSR1
SCHEMBL7666145 0.77 MAOB (0.58) ARMAOBCYP2C19MAPTNPSR1
SCHEMBL7661260 0.77 MAOB (0.41) CYP1A1CYP1B1CYP1A2GPR52AR
SCHEMBL7657806 0.75 AR (0.51) ARMAOBMAPTMEN1KMT2A
SCHEMBL7664261 0.75 AR (0.39) ABCG2ARMAOBMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500846-B1 2-(4-CHLOROPHENYL)-7-METHOXYCHROMEN-4-ONE, AS CYCLIN-DEPENDENT KINASE INHIBITORS, USED AS ANTICARCINOGENIC AGENTS OR FOR PROPHYLAXIS OF NEURODEGENERATIVE DISEASE LG CHEMICAL, LTD. (KR) 2002-12-31 US disclosed